CEMEX, S.A.B. de C.V. posts record 3Q25 margins from strong pricing, but volume concerns and high valuation raise caution.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, has selected Shiftconnector® to improve how it uses digital tools in manufacturing. By integrating Shiftconnector® into its ...
US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the European Commission (EC) has ...
JiMMYBAR! Launches First-to-Market Creatine Protein Bar -- The Future of Functional Fuel Has Arrived
JiMMYBAR! Functional Protein proudly announces the launch of the first-to-market Creatine Protein Bar, redefining the taste ...
NAPCO Security Technologies, Inc. , one of the leading designers and manufacturers of high-tech electronic security devices, wireless recurring communication services for intrusion, fire alarm, access ...
The all-fiberglass 1967 Mustang hides a 15.0:1 compression, 812-hp NASCAR heart and an attitude to melt asphalt—all while ...
Carter's, Inc. reported resilient revenues for Q3 '25, but operating margins & profits fell sharply, down 50% YOY. Learn more ...
A multinational analysis and Swedish registry data show higher dementia mortality after age 80 and a twofold dementia risk in ...
UBS upgrades Victoria’s Secret to ‘buy,’ raising its price target to $46 and forecasting a strong turnaround and 33% upside ...
Merck & Co, known as MSD outside of the USA and Canada, and Japan’s Eisai today announced that the Phase III LITESPARK-011 ...
A portable bass Bluetooth speaker brings that joy to life, creating powerful sound that you can carry anywhere. From lively ...
Patients with untreated advanced melanoma do not appear to gain a survival advantage from the addition of a cancer vaccine to pembrolizumab, suggests a trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback